Data scientists are making it easier to track COVID-19

They’re battling the coronavirus outbreak from behind their computer screens.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

While health officials scramble to treat the tens of thousands of people now infected with the novel coronavirus disease COVID-19, other experts are working tirelessly to tackle the virus from behind the computer screen.

“(T)he fighters of the battle are the doctors, nurses, and public health people in the field. They are the ones risking their lives,” Alessandro Vespignani, a computer scientist at Northeastern University, told IEEE Spectrum. “What we do as computer scientists and computational epidemiologists is provide them with intelligence to anticipate the move of the enemy.”

Analytical Approach

Vespignani’s contribution to the containment effort has taken the form of EpiRisk, a computer platform that simulates how the coronavirus could spread across 3,200 sub-populations in approximately 190 countries.

“We prioritized being informative over everything else.”


Soukarya Ghosh

His team at Northeastern University’s Laboratory for Modeling of Biological and Socio-technical Systems (MOBS Lab) regularly updates the simulation with new data on the coronavirus.

It pulls this data from publicly available sources, such as announcements from Chinese health authorities, and combines it with information on travel bans that could limit residents’ abilities to move between both adjacent areas and ones farther away.

Using EpiRisk, the MOBS Lab group created a list of the 25 countries at highest risk of importing new cases of COVID-19, which it plans to update throughout the outbreak as new data becomes available.

Knowledge Is Power

While Vespignani’s team attempts to predict the future of the coronavirus, a team of high school friends-turned-computer science undergrads is trying to keep the public informed about COVID-19’s present status.

They created TrackCorona, a website containing easy-to-digest information on the coronavirus, such as common symptoms, as well as near-real-time updates on its spread and officials’ containment efforts.

“We realized that this idea could potentially save lives by acting as a forewarning to those in dangerous regions, as the number of regions began growing at an exponential rate,” University of Virginia student Soukarya Ghosh told UVA Today. “So we prioritized being informative over everything else, laying out the website in a fashion that allows visitors to get real-time data without having to jump through hoops.”

Team Effort

Those are just two of the teams of computer scientists now engaged in what Vespignani described to IEEE Spectrum as “war time” mode: a hectic scramble to ensure that computer-powered insights into the coronavirus emergency evolve with the new data.

He told the outlet he’s been on global conference calls discussing the outbreak with upwards of 100 different research teams and agencies — and while he might view the health officials “in the field” as the true fighters in the war against COVID-19, it’ll likely require a combination of all these experts’ efforts to finally bring the outbreak to an end.

Related
Potato chips or heroin? The debate on social media and mental health
Experts disagree on whether social media causes mental health issues in adolescents despite looking at the same data. Here’s why.
Scientists have invented a method to break down “forever chemicals” in our drinking water
Researchers have discovered a way to eliminate “forever chemicals,” or PFAS, which usually take hundreds or thousands of years to break down.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
Up Next
zoonotic disease
Subscribe to Freethink for more great stories